CVE-2019-7256: Nice Linear eMerge E3-Series

Should you act?

Exploited: patch now if you run it

CISA has confirmed exploitation in the wild. This signal is computed from CISA KEV, EPSS and CVSS data; it is not an editorial verdict.

Yes, if you run Nice Linear eMerge E3-Series. CISA added this CVE to its Known Exploited Vulnerabilities catalog on 2024-03-25, which means there is reliable evidence of exploitation in the wild. US federal agencies must remediate by 2024-04-15; treat that as the outer limit, not the target.
EPSS 97.1%, percentile 99.9: FIRST’s model estimates a 97.1% chance of exploitation activity in the next 30 days, higher than 99.9% of all scored CVEs (very high). EPSS is a probability, not a verdict.
Remotely reachable with no login and no user interaction. If the vulnerable service is exposed to the internet, prioritize it.

Linear eMerge E3-Series devices allow Command Injections.

Nice Linear eMerge E3-Series contains an OS command injection vulnerability that allows an attacker to conduct remote code execution.

Weakness type: CWE-78.

Product: Nice Linear eMerge E3-Series · Assigned by: mitre · Published: 2019-07-02

Vendor	Product	Affected versions (per CVE record)
n/a	n/a	see vendor advisory

Scored by	CVSS	Score	Vector
CISA-ADP	3.1	9.8 Critical	`CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H`

CVSS measures how bad a flaw is if exploited, not how likely exploitation is. Read it next to the exploitation data below.

CISA KEV: added 2024-03-25; federal due date 2024-04-15. Known ransomware use: Unknown.
CISA required action: Contact the vendor for guidance on remediating firmware, per their advisory.
CISA SSVC assessment: exploitation active, automatable yes, technical impact total.
FIRST EPSS (model of 2026-10-21): 97.08% probability of exploitation activity in the next 30 days; percentile 99.9.

Original sources first. Version and fix details should always be confirmed against the vendor or project advisory.